Brooke L Fridley1,2, Junqiang Dai3, Rama Raghavan3, Qian Li3,2, Stacey J Winham4, Xiaonan Hou5, S John Weroha5,6, Chen Wang4, Kimberly R Kalli5, Julie M Cunningham7, Kate Lawrenson8,9, Simon A Gayther9,10, Ellen L Goode4. 1. Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas. brooke.fridley@moffitt.org. 2. Departmart of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida. 3. Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas. 4. Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota. 5. Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota. 6. Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota. 7. Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. 8. Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California. 9. Center for Bioinformatics and Functional Genomics, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California. 10. Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California.
Authors: Jaime I Davila; Pritha Chanana; Vivekananda Sarangi; Zachary C Fogarty; S John Weroha; Ruifeng Guo; Ellen L Goode; Yajue Huang; Chen Wang Journal: BMC Med Genomics Date: 2021-06-22 Impact factor: 3.063